MDL-100240 is used as a dual inhibitor of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) for the treatment of hypertension and cardiovascular diseases; it effectively lowers blood pressure, reverses left ventricular hypertrophy, prevents hypertrophy and dilation of the aorta and resistance arteries, reduces aldosterone levels, and attenuates severe hypertension and cardiovascular damage in transgenic rats by enhancing bradykinin effects and lowering adrenomedullin concentration.